mannitol has been researched along with Plasmodium vivax Malaria in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aebig, J; Durbin, AP; Ellis, RD; Fay, MP; Fontes, E; Lambert, L; Long, C; Mahanty, S; Malkin, EM; Miles, AP; Miller, LH; Miura, K; Muratova, O; Narum, D; Orcutt, A; Rausch, K; Saul, A; Shaffer, D; Song, G; Wu, Y; Zhu, D | 1 |
| Arevalo-Pinzon, G; Giraldo, MA; Mongui, A; Patarroyo, MA; Rodriguez, R; Rojas-Caraballo, J | 1 |
| Arévalo-Herrera, M; Cárdenas, W; Chen-Mok, M; Corradin, G; Fernández, OL; Herrera, S; Palacios, R; Ramírez, O; Vera, O | 1 |
| Bouillet, LÉ; Braga, EM; Bruna-Romero, O; Dias, MO; Dorigo, NA; Gazzinelli, RT; Moura, AD; Nosten, F; Renia, L; Rodrigues, MM; Russell, B; Soares, IS | 1 |
| Arévalo-Herrera, M; Castellanos, A; Herrera, S; Long, C; Miller, L; Mu, J; Rincón, A; Saul, A; Solarte, Y; Yasnot, MF | 1 |
| Arévalo-Herrera, M; Castellanos, A; Chitnis, CE; Dominik, R; Herrera, S; Shakri, AR; Yazdani, SS | 1 |
| Barnwell, JW; Bounngaseng, A; Collins, WE; Long, CA; McClure, H; Nace, D; Roberts, J; Saul, A; Strobert, E; Sullivan, JS; Williams, T | 1 |
| Barnwell, JW; Collins, WE; Dubovsky, F; Hensmann, M; Langermans, JA; Long, CA; Sattabongkot, J; Saul, A; Thomas, AW; Wu, Y | 1 |
| Barbosa, A; Dutta, S; Lanar, DE; Ockenhouse, CF; Ware, LA | 1 |
2 trial(s) available for mannitol and Plasmodium vivax Malaria
| Article | Year |
|---|---|
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
Topics: Adolescent; Adult; Animals; Antigens, Protozoan; Antigens, Surface; Disease Transmission, Infectious; Female; Humans; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Male; Mannitol; Middle Aged; Oleic Acids; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Recombinant Proteins; Vaccines, Synthetic | 2008 |
Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antibodies, Protozoan; Dose-Response Relationship, Immunologic; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunoglobulin G; Injections, Intramuscular; Interferon-gamma; Leukocytes, Mononuclear; Malaria Vaccines; Malaria, Vivax; Male; Mannitol; Oleic Acids; Plasmodium vivax; Protozoan Proteins; Time Factors | 2011 |
7 other study(ies) available for mannitol and Plasmodium vivax Malaria
| Article | Year |
|---|---|
Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Protozoan; Antigens, Protozoan; Aotus trivirgatus; Freund's Adjuvant; Humans; Immunity, Humoral; Malaria Vaccines; Malaria, Vivax; Mannitol; Oleic Acids; Plasmodium vivax; Protozoan Proteins; Recombinant Proteins | 2009 |
Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.
Topics: Adenoviridae; Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Hyaluronan Receptors; Immunity, Cellular; Immunity, Humoral; Immunization; Immunization, Secondary; Immunologic Memory; L-Selectin; Malaria Vaccines; Malaria, Vivax; Mannitol; Mice; Mice, Inbred BALB C; Oleic Acids; Plasmodium vivax; Protozoan Proteins; Recombinant Proteins; T-Lymphocytes; Vaccines, Synthetic | 2011 |
Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein.
Topics: Animals; Anopheles; Antibodies, Protozoan; Antigens, Protozoan; Antigens, Surface; Cebidae; Humans; Immune Sera; Malaria Vaccines; Malaria, Vivax; Mannitol; Oleic Acids; Plasmodium vivax; Recombinant Proteins; Vaccination | 2005 |
Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cebidae; Disease Models, Animal; Duffy Blood-Group System; Female; Freund's Adjuvant; Humans; Immunization; Malaria Vaccines; Malaria, Vivax; Male; Mannitol; Oleic Acids; Plasmodium vivax; Protozoan Proteins; Receptors, Cell Surface; Vaccines, Synthetic | 2005 |
Assessment of transmission-blocking activity of candidate Pvs25 vaccine using gametocytes from chimpanzees.
Topics: Alum Compounds; Animals; Anopheles; Antigens, Protozoan; Antigens, Surface; Female; Germ Cells; Macaca mulatta; Malaria Vaccines; Malaria, Vivax; Male; Mannitol; Oils; Oleic Acids; Plasmodium vivax; Vaccines, Combined | 2006 |
Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720.
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Anopheles; Antibodies, Protozoan; Antigens, Protozoan; Antigens, Surface; Female; Humans; Macaca mulatta; Malaria Vaccines; Malaria, Vivax; Male; Mannitol; Oleic Acids; Plasmodium vivax; Random Allocation; Recombinant Proteins | 2007 |
Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Animals; Antibodies, Protozoan; Cross-Linking Reagents; Disulfides; Escherichia coli; Lymphocyte Activation; Malaria Vaccines; Malaria, Vivax; Mannitol; Merozoite Surface Protein 1; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Oleic Acids; Plasmodium vivax; Protozoan Proteins; Recombinant Proteins; Vaccination; Vaccines, Synthetic | 2001 |